Clinuvel Pharmaceuticals Ltd. (CUVL)

Healthcare · Medical - Pharmaceuticals · NASDAQ · AU

$4.94-1.79%Close

COMPARE

CUVL

$4.94-1.79%

Overview Financials Earnings Analyst & RatingsAnalyst News Holders & ETFsHolders Options

RANGE

DATA 2026-10-23

LOPJLB.COM

OHLCOHLC, Essential layerEMAEMALEVELS, Essential layerSTOPStop, Essential layerFLIPFlip, Essential layer52W52-weekSIGNALS, Essential layerBUYBuy, Essential layerSELLSell, Essential layerEXHExhaustion, Essential layerEXH ZONEExhaustion zone, Essential layerCOILCoil

Oct 23, 2026O 5.00H 5.02L 4.93C 4.94-1.79%V 4.7K

Snapshot

Price & returns

1 week: -5.7%-5.3% vs SPY
1 month: -14.7%-13.7% vs SPY

Valuation

Market cap: $249.1M

Short interest & options

Short % float: 0.0%
Days to cover: 1.1
Short change: -54.4%

Signal: Call, Regime, Alignment, Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year

Price & returns: 3 years, 5 years

Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)

Signal evidence

How it works

Best Combo (today's action, held-out profit factor and family votes) · White Arrow (the call, its profit factor and closed trades) · Regime (today's regime and the regime model's profit factor) · Exhaustion (whether buyers or sellers are stretched today and the latest release)

Lists

Quality dividend stocks

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

About

Clinuvel Pharmaceuticals Ltd. (CUVL). Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CU…

SEC filingsCIK 1290877